Instructions for Authors

Click Here for Doc Version
Click Here for PDF Version

1. Aim and scope
Journal of pharmaceutical sciences and research (JPSR) is an international peer-reviewed multidisciplinary online journal publishing original research articles in pharmaceutical fields (pharmaceutics, pharmaceutical technology, pharmaceutical chemistry, pharmaceutical analysis, medicinal chemistry, biopharmaceutics, pharmacokinetics, pharmacology, toxicology, genomics and proteomics, pharmacognosy and phytochemistry) and scheduled to appear monthly. The journal accepts Review Articles, Original Articles and Short Communications.

2. Submission of Manuscript
Authors are invited to submit their manuscripts electronically through Journal's email address (jpsronline@gmail.com) along with a covering letter preferably by the corresponding author or first author. Each manuscript will be provided with a manuscript ID and all correspondence is done through e-mail. Please always refer to the manuscript ID for any further enquiries.

3. Organization of Manuscript
Manuscript should be typewritten in 12 font size, double-spaced, with margins of at least one inch on all sides. Pages should be numbered consecutively, starting with the title page and the matter arranged in the following order: Title page, Sections (Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion or Results and Discussion, Conclusions), Acknowledgements, References, Illustrations (Tables and figures along with caption and legends) and Tables and Figures captions and legends. Original Articles should have more than 14 pages, Review Articles in the range of 14-30 pages and Short Communications up to 14 pages, inclusive of illustrations.

3.1 Title Page: Title page contains title of the manuscript in bold face, title case (font size 14), names of the authors in normal face, title case (font size 12) followed by the address of authors in normal face, lower case (font size 12). Names of the authors should appear as initials followed by surnames. Full names may be given in some instances to avoid confusion. Followed by the author names, please provide the complete postal address or addresses with pin code number of the place(s), where the research work has been carried out. If the publication originates from several institutes, the affiliation of each author should be clearly stated by using superscript Arabic numbers after the name and before the institute. The author to whom correspondence should be directed must be indicated with an asterisk. At the bottom left corner of this page, please mention “*For correspondence” and provide a functional e-mail address of the corresponding author to whom all correspondence (including galley proofs) is to be sent.

3.2 Sections: Manuscripts should be divided into the following section titles (normal face, upper case) and subtitles in each section (bold face, lower case):
Abstract: An abstract not exceeding 250 words (for Short Communications between 60 and 80 words) should be provided typed on a separate sheet. Abstract should include aims, methods, results and conclusion.
Keywords: Up to 4-6 keywords must be provided in alphabetical order, preferably taken from Index Medicus. These keywords should be typed at the end of the abstract.
Introduction: It should be a concise statement of the background to the work presented, including relevant earlier work, suitably referenced. It should be started in a separate page after keywords.
Materials and Methods: It shall be started as a continuation to introduction on the same page. All important materials and equipments, the manufacturer’s name and, if possible, the location should be provided. The main methods used shall be briefly described, citing references. New methods or substantially modified methods may be described in sufficient detail. The statistical method and the level of significance chosen shall be clearly stated.
Results: The important results of the work should be clearly stated and illustrated where necessary by tables and figures. The statistical treatment of data and significance level of the factors should be stated wherever necessary. Data that is not statistically significant need only to be mentioned in the text - no illustration is necessary.
Discussion: This section should deal with the interpretation of results, making the readers to understanding of the problem taken and should be logical. The discussion should state the scope of the results, which need to be further explored. Results and discussion of the work can also be combined under one section, Results and Discussion.
Conclusions: Concisely summarizes the principal conclusions of the work and highlights the wider implications. This section should not merely duplicate the abstract.

3.3 Acknowledgements: Acknowledgements as well as information regarding funding sources should be provided.
3.4 References: Citations of literature within the text must be presented in numerical order and should be set in square brackets, thus [1, 12]. The cited literature are also collected in numerical order at the end of the manuscript under the heading “References”. Titles of journals should be abbreviated according to the practice of Chemical Abstracts. The abbreviated title and the volume number should appear in italics. Only the papers and books that have been published or in press may be cited. Please give the DOI (Digital Object Identifier) if the paper is not yet in print. Please note that website addresses must not be included as a reference, but should be inserted in the text directly after the information to which they refer.
Please note the following examples.

3.5 Tables: Should each be typed on a separate page, numbered in sequence with the body of the text. Tables should be headed with a short, descriptive caption. They should be formatted with horizontal lines only: vertical ruled lines are not required. Footnotes to tables should be indicated with a), b), c) etc. and typed on the same page as the table.

3.6 Figures: Should be on separate pages but not inserted with in the text. All figures must be referred to in the text and numbered with Arabic numerals in the sequence in which they are cited. Each figure must be accompanied by a legend explaining in detail the contents of the figure and are to be typed under the figures. Graphs and bar graphs should preferably be prepared using Microsoft Excel and submitted as Excel graph pasted in Word. Alternatively photographs can be submitted as JPEG images. Keys to symbols, abbreviations, arrows, numbers or letters used in the illustrations should not be written on the illustration itself but should be clearly explained in the legend. Avoid inserting a box with key to symbols, in the figure or below the figure. All Tables and Figures captions and legends should be typed on a separate page.

4. Article Proofs
Page proofs are sent to the designated author through e-mail. They must be carefully checked and returned the revised manuscript within 48 hours of receipt.

5. Copyright
Authors are asked to sign a warranty and copyright agreement upon acceptance of their manuscript, before the manuscript can be published. The Copyright Transfer Agreement can be downloaded here (in editable PDF).
Submission of your paper to this journal implies that the paper is not under submission for publication elsewhere. Material which has been previously copyrighted, published, or accepted for publication will not be considered for publication in this journal. Submission of a manuscript is interpreted as a statement of certification that no part of the
manuscript is copyrighted by any other publisher nor is under review by any other formal publication. By submitting your manuscript to us, you agree on Pharma Info Publisher copyright guidelines. It is your responsibility to ensure that your manuscript does not cause any copyright infringements, defamation, and other problems. Submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the Pharma Info Publisher or its Editorial Staff. The main author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility
of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.

6. Page Charges and Re-print
The journals published by Pharma Info Publisher are Open Access journals, which mean that the publication cost should be covered by the author's institution or research funds.